Ohio State is part of an 11-institution consortium to develop tools to make it easier to gather, analyze and interpret data generated by health sensors. The National Center of Excellence for Mobile Sensor Data-to-Knowledge (MD2K) will be established with a $10.8 million award from the National Institutes of Health (NIH). The MD2K team, led by the University of Memphis, will design novel big data solutions that will reliably quantify and interpret physical, biological, behavioral, social and environmental factors that contribute to health and disease risk. Researchers will apply new technologies to two health care challenges with high mortality rates: reducing hospital readmissions among congestive heart failure patients and preventing relapse among people who have quit smoking. At Ohio State, William Abraham, director of cardiovascular medicine at the Wexner Medical Center, will lead clinical studies of technologies developed for heart failure care. Emre Ertin, research assistant professor of electrical and computer engineering, who specializes in signal processing required to interpret sensor data, will design the novel biosensors. Clay Marsh, chief innovation officer for the Wexner Medical Center and professor of internal medicine, will direct the pursuit of health care innovations enabled by the center’s initial work.